Case Study: Insulin Sensitizers as Enhancers in Diabetes Management - Pharmacy Times
7/14/2022 12:00:00 AM2 years 9 months ago
by Dena Homayounieh, PharmD, MSc, Gauri Sabnis, PhD, Marina Dykhne PharmD, BCACP, APh, CDCES
by Dena Homayounieh, PharmD, MSc, Gauri Sabnis, PhD, Marina Dykhne PharmD, BCACP, APh, CDCES
The objective of this study is to evaluate the use of low-dose pioglitazone, without relying on high doses of insulin, by enhancing sensitivity as a suitable, cost-effective strategy compared to larger insulin doses in patients with limited access to care.
Thiazolidinediones (TZDs) enhance insulin activity and reverse insulin resistance, a common characteristic of type 2 diabetes.1 These agents are ligands for peroxisomal proliferator-activated recepto… [+11383 chars]
full article...